Axogen, Inc.
AXGN· Nasdaq
Released Feb 24, 2026, before the open
10-K filed Feb 24, 2026, 55 days after period end · 0000805928-26-000031
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | $59.90M | $49.40M | $42.92M | $36.16M |
| Net Income | -$13.16M |
Axogen, Inc. · CIK 805928 · Engraved from SEC EDGAR
| $450.00K |
| -$3.89M |
| -$5.42M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.